From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial
Authors:
- Lisa De CockLCLisa De Cock
- Cédric DraulansCDCédric Draulans
- Floris J. PosFPFloris J. Pos
- Sofie IsebaertSISofie Isebaert
- Robin De RooverRRRobin De Roover
- Uulke A. van der HeideUHUulke A. van der Heide
- Robert J. SmeenkRSRobert J. Smeenk
- Martina Kunze-BuschMKMartina Kunze-Busch
- Jochem van der Voort van ZypJZJochem van der Voort van Zyp
- Hans de BoerHBHans de Boer
- Linda G.W. KerkmeijerLKLinda G.W. Kerkmeijer
- Karin HaustermansKHKarin Haustermans
- 11 May 2023
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 185, 109713
Abstract
No abstract availableKeywords
Funding Information
- Kom op tegen Kanker
This publication has 24 references indexed in Scilit:
- Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trialRadiotherapy and Oncology, 2018
- Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate CancerJournal of Clinical Oncology, 2017
- Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trialThe Lancet Oncology, 2016
- Radiobiology of tissue reactionsAnnals of the ICRP, 2015
- The role of overall treatment time in the outcome of radiotherapy of prostate cancer: An analysis of biochemical failure in 4839 men treated between 1987 and 1995Radiotherapy and Oncology, 2010
- Stereotactic Body Radiotherapy for Localized Prostate Cancer: Interim Results of a Prospective Phase II Clinical TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Hypofractionation in Prostate Cancer: How Far Can We Go?Clinical Oncology, 2008
- Does Treatment Duration Affect Outcome After Radiotherapy for Prostate Cancer?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- What hypofractionated protocols should be tested for prostate cancer?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Interpreting the significance of changes in health-related quality-of-life scores.Journal of Clinical Oncology, 1998